PGEN Precigen Corp: רווח נקי למניה ב-12 החודשים האחרונים

The annual EPS TTM percentage growth chart for Precigen, Inc. (PGEN) illustrates profit dynamics, where the parameter value equals 104.60. A strong patent portfolio in rare disease therapies creates potential despite trial volatility. Financial equilibrium is maintained through the optimization of research costs. The security of innovation deliveries is ensured via air transport and cryogenic storage of biomaterials.
PGEN (Intrexon): פילוחים אנליטיים ודוחות לפי אינדיקטורים

The annual growth rate of earnings per share measures the efficiency of business capitalization, allowing investors to filter out market volatility and assess the real margin of safety through EPS dynamics over the last 12 months year-over-year. For Precigen, Inc. (PGEN), this indicator is critically important, as it weighs the massive expenditures on synthetic biology and UltraCAR-T against the actual ability to generate value.